The c-Jun N-terminal protein kinases (JNKs), also called stress-activated protein kinases, are members of the growing family of serine/threonine kinases in the mitogen-activated protein (MAP) kinase superfamily. Like other MAP kinases, JNKs are activated via phosphorylation on adjacent threonine and tyrosine residues and can be inactivated by a unique family of dual specificity phosphatases, called MAP kinase phosphatases (MKPs). MKPs are encoded by immediate early genes and induced in response to environmental stressors and growth factor stimulation. Two prevalent isoforms of MKP, MKP1 and MKP2, are co-expressed in a wide variety of cell types. In this study, we examined the actions of MKP1 and MKP2 on JNK1 and JNK2. JNK1 phosphorylation and activation was inhibited by expression of both MKP1 and MKP2, although MKP1 selectivity toward JNK1 appeared significantly higher than that of MKP2. In contrast, JNK2 activity was inhibited by either phosphatase to similar degrees. Both MKP1 and MKP2 were highly effective at blocking the activation of the physiological target of JNK activation, the transcription factor c-Jun. In PC12 cells, MKP1 and MKP2 are transcriptionally induced following stimulation by nerve growth factor. In these cells, UV light-evoked JNK activation was reduced by pretreatment with nerve growth factor. Therefore, JNKs may be selective targets of MKP action in certain cells.
Mitogen-activated protein (MAP) 1 kinases are a unique family of serine/threonine kinases that are activated via reversible phosphorylation and mediate signal transduction for multiple extracellular stimuli. In mammalian cells, at least two MAP kinase pathways have been extensively characterized: the extracellular signal-regulated protein kinase (ERK) cascade, which is responsible for signal transduction involving growth and differentiation, and the stress-activated protein kinase (1) or c-Jun N-terminal protein kinase (JNK) cascade, which mediates the cellular responses to proinflammatory cytokines and genotoxic stress (2) . ERKs and JNKs are specifically activated by distinct isoforms of upstream MAP/ERK kinases (MEKs or MKKs) and can be inactivated in vitro (3) and in vivo (3) (4) (5) (6) (7) (8) by a novel class of dual specificity phosphatases collectively termed MAP kinase phosphatases (MKPs). The contrasting cellular responses dictated by ERK and JNK activation are regulated in part by the coordinate effects of MEKs and MKPs upon their respective substrates.
MKPs are the products of immediate early genes whose mRNA is rapidly induced following such divergent stimuli as serum, epidermal growth factor and NGF (3, 9), short-wave UV light and DNA-alkylating agents (8) . MKP activity is directed toward the homologous tripeptide phosphorylation sites required for ERK and JNK activation, TEY and TPY, respectively (10 -14) , and MKP actions have thus far been confined exclusively to the MAP kinase family of proline-directed kinases. The prototype dual specificity phosphatase (VH1) was identified first in vaccinia; however, homologs were soon isolated in yeast (Yop51 and MSG5), humans (CL100, PAC1, VH3, and B23), mice (MKP1, 3CH134, and Erp) (15) (16) (17) (18) (19) (20) (21) , and rats (MKP2 and VH6) (9) . Of the current isoforms, PAC1 is present only in hematopoietic cells (19) , while MKP1 and MKP2 are expressed more ubiquitously and with overlapping tissue distributions (9) . Sequence comparisons between MKP1 and MKP2 demonstrate a highly conserved catalytic core but substantial disparity within the N-terminal domain. Although significant differences in substrate specificity, post-translational regulation, or subcellular localization might be expected, none have yet been identified (6, 9) .
Early investigations proposed a role for MKPs as inactivators of ERKs following serum stimulation (3, 22) ; however, subsequent studies have demonstrated that growth factor-induced transcription of MKP1 and MKP2 did not correspond temporally with ERK inactivation (9, 23) , and other mechanisms governing cessation of ERK activity following these stimuli have since been proposed (24 -27) . More recently, MKPs have been implicated in the regulation of JNK activity (8, 28) . Ten isoforms of JNK have been isolated, but analysis of their nucleotide sequences suggests that all are the likely products of alternative processing of the transcripts of only three genes (28) . Of these numerous isoforms, JNK1, originally isolated from fetal brain (11) and JNK2, isolated from HeLa (12) and Jurkat (29) cells, have been studied most extensively. JNK3 and its isoforms were only recently characterized (28) . MKP actions upon JNKs have been studied previously, but with the goal of simply establishing whether MKPs could inactivate JNK (8, 28) or as an element of investigations toward potential substrate specificities of MKPs between MAP kinase families (6) . Direct comparisons of substrate specificities for MKPs among JNK isoforms has not been closely examined. We therefore studied in detail the actions of MKP1 and MKP2 on the kinase activity of the two best characterized isoforms of JNK, JNK1 and JNK2, and compared these effects with the inhibi-tion of JNK-induced gene activation via the transcription factor c-Jun. Additionally, we examined the potential role of MKP induction in regulation of the JNK activity following growth factor activation of the ERK signal transduction cascade.
EXPERIMENTAL PROCEDURES
Materials-The anti-ERK2 (C-14) antibody, anti-JNK1 (FL) antibody, and the anti-MEK kinase (C-22) antibody were purchased from Santa Cruz Biotechnology. The anti-flag antibody (murine M2) was purchased from Kodak Scientific Imaging Systems. The anti-PAC1 antibody was provided courtesy of Dr. Steven Pelech (Kineteck, Vancouver, British Columbia, Canada). GST-c-Jun was bacterially expressed using a plasmid construct provided by Dr. David Parker (Oregon Health Sciences University), and purified protein was prepared according to published protocols (30) . [␥-
32 P]ATP was purchased from DuPont NEN, and NGF was obtained from Boehringer Mannheim.
Cell Culture and Growth Factor Treatment-COS-7 cells were provided by ATCC and were grown at 5% CO 2 in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, and 5% L-glutamine. PC12-GR5 cells were provided by Rae Nishi (Oregon Health Sciences University) and were grown at 5% CO 2 in Dulbecco's modified Eagle's medium containing 5% fetal calf serum, 10% horse serum, and 5% L-glutamine. Cells were serum-starved for 16 h in Dulbecco's modified Eagle's medium alone prior to treatment with NGF (100 ng/ml).
Plasmids-Full-length MKP1 cDNA (1.9-kilobase pair HindIIIBamHI fragment) was provided by Dr. Nicholas Tonks (Cold Spring Harbor Laboratories). A truncated MKP2 cDNA fragment (2.4-kilobase pair Eco-RV fragment) subcloned into pcDNA3 (Invitrogen) under the CMV promoter was cloned and previously characterized by our laboratory (9) . Full-length JNK1 and ERK2 cDNA subcloned into the pcDNA3 vector were provided by Dr. Richard Maurer (Oregon Health Sciences University). Full-length JNK2, fused to the flag epitope and subcloned into pCMV5 was provided by Dr. Roger Davis (Howard Hughes Medical Institute, Worcester, MA). A constitutively active truncated MEK kinase (⌬MEKK) in pCMV5, pCMV5-MEKK, was provided by Gary Johnson (National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado). The 5xGal4-E1B-luciferase plasmid was a gift of Richard Maurer (Oregon Health Sciences University) and has been described previously (9) . The Gal4-c-Jun plasmid was a gift of Richard Goodman (Vollum Institute).
Transient Transfection-80% confluent COS-7 cells were co-transfected with the combinations of plasmids indicated using the standard calcium phosphate co-precipitation method (Life Technologies, Inc.). The parent vector, pcDNA3, was added in all experiments to equalize the total amount of transfected DNA. Cells were incubated in precipitate overnight and then washed three to five times (until free of precipitate) and allowed to recover in serum-containing media for an additional 24 h prior to either serum starvation and treatment or harvesting. For experiments involving MEKK and JNK1, COS-7 cells were co-transfected with 1 g of the constitutively active truncated MEK kinase (⌬MEKK), 10 g of JNK1, and 10 g of either MKP1 or MKP2. In other experiments, the quantities of transfected cDNAs are indicated.
ERK Immune Complex Assay-Transfected cells were washed twice in phosphate-buffered saline (PBS) and then lysed in buffer containing 10% sucrose, 1% Nonidet P-40, 20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 10% glycerol, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, 1 mM sodium orthovanadate, and 10 mM sodium fluoride. Lysates were centrifuged at low speed to remove nuclei, and the supernatant was assayed by the method of Bradford (31) to determine total protein concentration. Samples containing 100 g of total protein were then immunoprecipitated in a total of 500 l of lysis buffer with an agarose-conjugated antibody to ERK2 (C-14) (Santa Cruz Biotechnology) overnight at 4°C. Immunoprecipitated ERK2 was then washed three times in wash buffer containing 50 mM Tris-HCl (pH 7.3), 0.2% Nonidet P-40, 0.5 M NaCl, 1 mM phenylmethylsulfonyl fluoride, and 5% sucrose (w/v). Kinase activity was determined by incubation with 10 g of myelin basic protein and 5-10 Ci of [␥-
32 P]ATP in 50 l of assay buffer containing 80 mM Hepes (pH 7.4), 80 mM MgCl 2 , 0.1 mM ATP, 2 mM sodium orthovanadate, and 20 mM sodium fluoride for 30 min at 30°C. Reactions were terminated via the addition of 65 l of Laemmli sample buffer and analyzed by SDS-polyacrylamide gel electrophoresis. Quantitation was performed following scanning the gel with a PhosphorImager 445SI (Molecular Dynamics, Inc.).
JNK1 and JNK2 Immune Complex Assays-Cells were transfected as indicated above. Treated and untreated cells were then washed twice in PBS or HPS (20 mM Hepes-KOH (pH 7), 150 mM NaCl) and harvested in a stress-activated protein kinase lysis buffer containing 20 mM Hepes-KOH (pH 7.4), 2 mM EDTA, 50 mM ␤-glycerophosphate, 10% glycerol, 1% Triton X-100, 1 mM dithiothreitol, 1 mM sodium orthovanadate, 0.4 mM phenylmethylsulfonyl fluoride, 0.5 g/ml aprotinin, and 0.5 g/ml leupeptin. Lysates were centrifuged at low speed to separate nuclei, and the supernatant was assayed for total protein concentration via the method of Bradford (31) . Samples containing 100 g of total protein were immunoprecipitated overnight at 4°C with an agaroseconjugated anti-JNK1 (FL) antibody (Santa Cruz Biotechnology), or, for JNK2 kinase assays, anti-M2 antibody (Eastman Kodak Co.) and Protein G-Sepharose (Pierce). The immunoprecipitated JNK was then washed twice in LiCl buffer (500 mM LiCl, 100 mM Tris-HCl (pH 7.6), 1 mM dithiothreitol, and 0.1% Triton X-100) and three times in assay buffer (20 mM MOPS (pH 7.2), 10 mM MgCl 2 , 2 mM EGTA, 1 mM dithiothreitol, and 0.1% Triton X-100) and assayed for kinase activity via incubation with 3 g of GST-c-Jun and 1 Ci of [␥-
32 P]ATP in 50 l of assay buffer for 30 min at 30°C. Reactions were terminated by the addition of 65 l of Laemmli sample buffer, and samples were analyzed by SDS-polyacrylamide gel electrophoresis. Quantitation was determined by scanning the gel using a PhosphorImager.
UV Light Treatment of Cells-Stimulation of JNK activity with ultraviolet light was achieved using the available bactericidal lamps employed in tissue culture hoods. UV energy was measured using an ultraviolet light meter (Questar Microsystems, Inc., Woodinville, WA; model LT1000). UV output was determined to be from 0.05 to 0.20 J s Ϫ1 m
Ϫ2
. Cells were treated for a duration of 60 s or a total delivered UV dose of 3-12 J m Ϫ2 . Western Blotting of COS-7 Proteins-Treated and untreated cells were washed twice in PBS and lysed in stress-activated protein kinase buffer as described above. Lysates were centrifuged at low speed to remove nuclei, and total protein concentration was determined by the Bradford method (31). Samples containing 25 g of total protein were resolved on a 12% SDS-polyacrylamide gel and transferred onto an Immobilon P membrane using a semidry transfer apparatus (Bio-Rad). Membranes were blocked using blocking buffer containing 10% (w/v) dry milk (Carnation) in PBS with 0.15% Tween. Membranes were probed with anti-JNK1 antibody (diluted at 1:10,000) (Santa Cruz Biotechnology, Inc.), anti-MEKK antibody (diluted at 1:1000), anti-PAC1 antibody (diluted at 1:1000), or anti-phosphotyrosine antibody (diluted at 1:1000). Other samples containing 100 g of total protein were immunoprecipitated overnight with an anti-JNK1 antibody, and the immunoprecipitate was washed in LiCl and assay buffers as described for the JNK immune complex assay above. These samples were then resolved on a 12% SDS-polyacrylamide gel and transferred to Immobilon P membrane and probed with anti-phosphotyrosine antibody (diluted at 1:1000). A horseradish peroxidase-conjugated secondary antibody was utilized to allow detection of the appropriate bands using enhanced chemiluminescence (Amersham Corp.).
Jun/Gal Assay-As described previously, COS-7 cells were co-transfected using the calcium phosphate method with the various combinations of the following plasmids: 1 g of pCMV5-MEKK, 5-20 g of pcDNA3-MKP1, 5-20 g of pcDNA3-MKP2, and 10 g of pcDNA3-JNK1. To determine the transcriptional activation of c-Jun, we utilized a mammalian two-hybrid system. Cells were also transfected with 3 g of 5xGal4-E1B-luciferase with or without 3 g of Gal4-c-Jun, as indicated. As with all studies, the parent vector pcDNA3 was added to each set of transfections to equalize the total amount of transfected DNA. Twelve hours after transfection, cells were washed free of precipitate and allowed to recover in serum-containing medium for an additional 36 h. Cells were then harvested for the luciferase assay. Briefly, cells were washed twice in PBS, harvested in 1 ml of PBS, following low speed centrifugation, and lysed by freeze-thawing three times in 100 mM K 2 PO 4 , pH 7.8. The lysate was centrifuged at high speed, and the supernatant was assayed for luciferase activity using a luminometer (AutoLumat LB953). Protein assays were performed on the remaining supernatant by the method of Bradford (31) , and all raw data were normalized to light units/g of total protein.
RESULTS

MKP1 and MKP2 Inactivate ERK2 in COS-7 Cells in Vivo-
COS-7 cells were initially chosen for study because of their ability to replicate and overexpress plasmids containing the SV-40 origin of replication, thus allowing direct monitoring of all transfected and expressed proteins. To confirm the efficacy of COS-7 cells as a model for MKP activity in vivo, we examined the ability of MKP1 and MKP2 to inactivate ERK2 following stimulation with a truncated Raf-1, BxB-Raf, that is a constitutive activator of ERKs (32) . COS-7 cells were transfected with a cDNA encoding ERK2 and co-transfected with vector alone, 1 g of BxB-Raf, or BxB-Raf plus 10 g of MKP1 or MKP2. Cells were harvested 48 h after transfection, and ERK activity was determined via an immune complex assay. Transfection of vector alone or ERK2 alone produced no detectable ERK activity (Fig. 1) . Transfection of BxB-Raf with ERK2 produced a large increase in ERK activity as assayed by [␥- 32 P]ATP-labeled myelin basic protein, while co-transfection of 10 g of either MKP1 or MKP2 cDNA reduced assayed ERK2 activation nearly to base line. These results confirm that MKPs can be expressed in COS-7 cells to inactivate a co-transfected substrate.
MEKK-induced JNK1 Activity Is Blocked by Co-transfection of MKP1 and MKP2-Using COS-7 cells, we then examined the capability of either MKP to inactivate JNK1. Constitutively active MEKK (⌬MEKK) is a potent stimulus for JNK activation (33, 34) . No JNK1 kinase activity was evident in lysates prepared from cells transfected with vector or JNK1 alone ( Fig.  2A) . Co-transfection with ⌬MEKK produced robust JNK1 activation, but this activation was almost completely eliminated following transfection with the cDNA for MKP1 and was significantly reduced in the presence of MKP2 (Fig. 2A) . The activation of endogenous JNKs by ⌬MEKK was not detectable in this assay and is presumably secondary to the small percentage of the cells transfected with ⌬MEKK. These results demonstrate the specificity of this assay for transfected JNK1.
Transient Transfection of MKP1 and MKP2 Inhibit MEKKinduced JNK1 Tyrosine Phosphorylation-To establish whether the reduction in JNK1 kinase activity by MKP1 and MKP2 corresponded to reductions in JNK1 tyrosine phosphorylation, cell lysates were prepared and examined for JNK1 phosphotyrosine content by immunoprecipitation with an agarose-conjugated anti-phosphotyrosine antibody followed by Western blotting with anti-JNK1 antibody (Fig. 2B) . No detectable phosphorylated JNK was seen in cells transfected with vector alone or with vector containing JNK1 in the absence of the activated MEKK. Co-transfection of 1 g of ⌬MEKK produced marked phosphorylation of the substrate JNK1. More importantly, the addition of 10 g of MKP1 resulted in a significant reduction in JNK1 phosphorylation to levels seen with transfection of JNK1 alone, while co-transfection of MKP2 with MEKK reduced JNK1 phosphotyrosine content by more than 50%. Thus, both MKP1 and MKP2 dephosphorylate and inactivate MEKK-stimulated JNK1.
Cotransfection of Multiple Plasmids Does Not Alter Levels of Transfected Proteins in COS-7
Cells-Because the results of the above Western blots and immune complex assays may have been contingent not only upon MKP's actions upon JNK1 but upon the degree of plasmid replication and translation of the transfected cDNAs encoding JNK1, MKP1 or MKP2, and ⌬MEKK, we examined protein expression of all transfected components via Western blotting. Lysates from COS-7 cells exhibited high levels of protein expressed from transfected cDNAs as determined by anti-MEKK (A), anti-JNK1 (B), and antiserum to PAC1 (C) that recognizes both MKP1 and MKP2 (Fig. 3) . Furthermore, despite co-transfection with multiple plasmids, levels of protein expression for each transfected component were nearly identical. These results also demonstrate that, under the conditions of this assay, the JNK1 antisera recognized only transfected JNKs and did not recognize endogenous JNK1 or other JNKs reported to be recognized by this antibody (12) . Also, these data show that variations in JNK1 activity and tyrosine phosphorylation were dependent solely upon the presence or absence of co-transfected MKP1 or MKP2.
JNK1 Inactivation by MKP1 and MKP2 Is Dose-dependentAlthough both MKP1 and MKP2 demonstrate phosphatase activity toward JNK1, only MKP1 consistently produced complete elimination of all detectable JNK1 phosphorylation and activity. Therefore, we examined the dose dependence of both phosphatases on JNK1 activity in COS-7 cells (Fig. 4) . In the presence of 1 g of ⌬MEKK, co-transfection of only 5 g of MKP1 cDNA produced marked diminution of JNK1 activity as determined by immune complex assay, whereas a similar amount of MKP2 cDNA resulted in a reduction of only approximately 50% of measured JNK1 activity. Thirty g of transfected MKP2 cDNA were required to produce the equivalent reduction in JNK1 activity produced by 5 g of transfected MKP1 cDNA. This suggests that, in COS-7 cells overexpressing both JNK and MKPs, MKP1 may be more selective for JNK1 than MKP2.
Transient Transfection of MKP1 or MKP2 Inhibits UV Lightstimulated JNK1 Activity in COS-7 Cells-To examine whether JNK1 was inhibited by MKPs in the presence of stimuli other than ⌬MEKK, we examined JNK activity following exposure to UV light. Treatment of COS-7 cells with UV light (3-12 J/m 2 ) produced JNK activation with a time course consistent with that reported by other investigators for different cell types (11) . Prior to examining the action of transfected MKPs on JNK activity following UV stimulation, we determined whether activation of transfected JNK1 could be detected above activated endogenous JNKs. Since the expression of transfected MKPs should be limited to the cells that are co-transfected with JNK1, the activation of endogenous JNKs by UV light will persist, even following complete inhibition of transfected JNKs by co-transfected MKPs. Total JNK1 activity as determined by immune complex assay was more than 150% of that in cells transfected with vector alone (Fig. 5) . Moreover, co-transfection of JNK1 cDNA and subsequent overexpression of JNK1 did not alter the time course of activation. Transfection of MKPs in the absence of co-transfected JNK1 did not result in decreased endogenous JNK activity following UV stimulation, 2 suggesting that MKP expression was limited to a fraction of the cells. Co-transfection of MKP1 or MKP2 assayed at both 30 and 60 min following UV light exposure resulted in significant decreases in JNK activity to levels approaching that seen in the absence of transfected JNK1. The addition of MKP1 reduced UV-stimulated JNK1 activity to those levels seen in COS-7 cells transfected with vector alone, while MKP2 was less effective in diminishing JNK1 activation, especially at 30 min following UV treatment. Thus, both MKP1 and MKP2 function to inhibit JNK activation in response to multiple upstream stimuli. Under both conditions, MKP1 exhibited increased activity toward JNK1, as compared with MKP2.
MKP1 and MKP2 Inhibit JNK-dependent Gene ExpressionThe physiological target of JNK1 is the transcription factor c-Jun, which is transactivated following phosphorylation of serine residues in the NH 2 -terminal domain (35) . c-Jun is a component of the AP-1 transcriptional complex and, when activated, induces the transcription of numerous immediate early genes including c-fos and c-jun itself (36) . Multiple JNKs have been identified at present (28) , showing characteristic binding and phosphorylation of c-Jun substrates (29) . To measure transactivation of c-Jun, we used a mammalian two-hybrid system involving a chimeric Gal4/c-Jun cDNA construct to direct expression of the 5xGal4-E1B luciferase plasmid. In this assay, activation of luciferase activity is dependent on the phosphorylation and activation of the Gal4/c-Jun chimera (7, 35) . Transfection of ⌬MEKK increased luciferase activity, confirming that MEKK can activate c-Jun in COS-7 cells. Furthermore, this activation is specific; constitutively active MEK-1 (37, 38) did not stimulate luciferase activity in this assay. measured JNK1 activity directly. In contrast to their actions on transfected JNK1, MKP2 and MKP1 were equally proficient blocking c-Jun activation. Although this difference may reflect uncoupling of JNK and c-Jun activation, it is also possible that, unlike the kinase activity of transfected JNK1, c-Jun activation was only partially dependent on transfected JNKs. We therefore examined the contribution of endogenous JNKs on c-Jun activation by repeating the previous experiment in the absence of co-transfected JNK1 (Fig. 6B) . c-Jun activation by endogenous JNKs was readily detectable, although total luciferase activity was decreased in the absence of transfected JNK1. MKP1 and MKP2 inhibited endogenous JNK activity in a dosedependent manner. In these experiments, MKP2 was a more potent inhibitor of c-Jun activation than was MKP1. This is in contrast to the actions of MKP2 on the kinase activity of transfected JNK1. Thus, despite the higher activity toward JNK1, MKP1 is a less effective inhibitor of endogenous JNKs, and the reverse appears true for MKP2.
JNK2 Activity Is Inhibited by MKPs-JNK2 is a second abundant isoform of the class of c-Jun N-terminal kinases, and like its predecessor JNK1, it is activated following cellular stress by similar dual specific kinases (1, 11) . JNK2 has been demonstrated to have a higher affinity for and activity toward the transcription factor c-Jun, both in vitro and in vivo (12) , suggesting that it may be the more important of the two isoforms for physiological regulation of c-Jun activity. To examine the regulation of JNK2 by MKPs, COS-7 cells were transiently transfected with vector alone, JNK2 alone, or ⌬MEKK plus JNK2 along with increasing amounts of MKP1 or MKP2. Results are shown in Fig. 7 . In panel A, kinase activity was dependent on transfected JNK2, demonstrating that the JNK1 antisera used recognized JNK2, as reported (12) . The basal activity of transfected JNK2 was minimal but was markedly increased upon co-transfection of ⌬MEKK. The addition of either MKP1 or MKP2 significantly blunted JNK2 activation by ⌬MEKK, and this inhibition, like that of JNK1, showed dose dependence. In contrast to its inhibition of JNK1, MKP2 was more effective at inhibiting the kinase activity of JNK2, especially at lower doses. In panel B, whole cell lysates were immunoprecipitated with a monoclonal M2 antibody directed at a flag epitope contained within the JNK2 cDNA. This antibody allowed us to examine transfected JNK2 without the potential contribution of endogenous JNKs (12) . When JNK2 was assayed using this antibody, both MKP1 and MKP2 showed similar inhibition of this kinase activity. Thus, while MKP1 appears better than MKP2 at inhibiting JNK1, both phosphatases are similar in their inhibition of transfected JNK2.
NGF Blocks JNK Activation following UV Light-Both MKP1 and MKP2 are transcriptionally induced following growth factor stimulation in PC12 cells (9) . To examine whether the induction of endogenous MKPs is associated with a concomitant reduction in JNK activity, we measured UV light-induced JNK activity in PC12 cells with and without prior NGF stimulation. PC12 cells were serum-starved overnight and then treated with UV radiation (3-12 J m Ϫ2 ) alone or after pretreatment with NGF 100 ng/ml 2 h prior to exposure. This time course was chosen, since our laboratory has previously demonstrated significant increases in MKP mRNA during the first 1-2 h following NGF treatment (9) . Protein levels of MKPs followed this increase as well. 2 As illustrated in Fig. 8 , NGF pretreatment significantly blunted UV light-induced activation of JNK as compared with cells pretreated with serum-free medium alone. The ability of induced MKPs to reduce JNK activity may be limited by the UV treatment itself, which may induce a rapid fall in MKP protein levels (22, 39) . These results demonstrate that NGF pretreatment reduces the maximal level of JNK activation following UV stimulation with kinetics that are consistent with the induction of MKPs. DISCUSSION MAP kinase phosphatases comprise a class of dual specificity phosphatases that are expressed in a wide variety of tissues and are transcriptionally induced in response to diverse extracellular signals. Some, like PAC1, show restricted tissue distribution, while others, such as MKP1 and MKP2, are broadly expressed, often within the same cells (9) . Although a recently identified a novel MKP isoform, MKP3 (40, 41) or Pyst1 (26) , has been shown to possess specificity toward ERKs alone, identification of definitive in vivo substrate selectivities between MKP1 or MKP2 has has been elusive. The only demonstrated divergence thus far has been the inhibition of the JNK-related stress-activated protein kinase p38 by MKP1 but not MKP2 in COS-7, NIH-3T3, and HeLa cells (6) , although this finding appears to be cell type-specific, since MKP2 has been shown to be a potent inhibitor of p38 in PC12 cells (42) . The expansion of the mammalian family of MAP kinases by the discovery of JNK1 and JNK2 and other JNKs (11, 28, 29) raised the possibility that various isoforms of these related kinases might be differentially regulated by MKP1 and MKP2. We subsequently examined the actions of MKP1 and MKP2 on the two well characterized isoforms of JNK, JNK1 and JNK2 (6) .
COS-7 cells were chosen for study because of their ability to provide high levels of expression of transfected kinase to produce a robust signal that could be easily detected above background activity (43) . The validity of this method was first examined by confirming the known activity of MKPs on ERKs using BxB-Raf as the upstream activator (9, 32, 44) . Using similar techniques, we demonstrated that JNK can be inactivated in vivo by both MKP1 and MKP2 using ⌬MEKK as the stimulator of JNK activation (Fig. 2) . Importantly, JNK activity was dependent on transfected JNK; both basal and stimulated levels of endogenous JNKs in untransfected cells were barely detectable compared with that in transfected cells. Therefore, assayed JNK kinase activity in cells co-transfected with MKPs is an accurate reflection of the specific activity of MKPs toward transfected substrate. Overall, in COS-7 cells, MKP1 exhibited similar activities for both isoforms of JNK, while MKP2 activity appeared to favor JNK2. This does represent a minor difference from other recent data suggesting that MKP1 is a more potent inhibitor of JNK2, and it has been suggested that overexpression of the products of transfected plasmids in COS-7 cells hinders interpretation of substrate specificities (6) . We believe, however, that in our experiments, under conditions where protein expression is monitored, findings using this expression system can be quantitative. Tyrosine phosphorylation of JNK1 was also examined (Fig. 2) , and inactivation of JNK1 was unsurprisingly found to be associated with tyrosine dephosphorylation, which paralleled decreased JNK1 activity tightly. Although not specifically assayed, it is likely that threonine dephosphorylation followed similar kinetics (45) (46) (47) (48) .
Short-wave UV light and ␥-irradiation are reliable stimulators of stress activated pathways and can activate JNKs in multiple cell types (8, 11) . In Fig. 5 , UV irradiation of COS-7 ) in the presence or absence of prior treatment with 100 ng/ml NGF, applied 120 min prior to the initiation of irradiation. JNK activity was assayed via immune complex assay using GST-c-Jun as substrate, as described under "Experimental Procedures." B, JNK activity is shown as a function of time following treatment with UV light, in the presence (circles) and absence (squares) of NGF pretreatment. Activity is normalized to maximal levels achieved (60 min, UV stimulation). Data represented are the means Ϯ S.E. of three independent experiments. cells produced a predictable rise in endogenous JNK activity with a time course consistent with that previously reported for other cell types (8) and was not altered by transfection of JNK1. Importantly, the augmentation of JNK activity by the expression of transfected JNK1 permitted the specific evaluation of the effects of transfected MKPs on JNK1 activity, despite the co-activation of endogenous JNKs. As in the experiments using ⌬MEKK, MKP1 was more effective than MKP2 in inhibiting JNK1 following its activation. Although MKP1 and MKP2 demonstrate varying activities toward JNKs when overexpressed in COS-7 cells, we cannot rule out the possibility that endogenous MKPs may have different selectivities toward JNKs in other cells or when expressed to lesser degrees.
To examine whether MKP activity was reflected in JNK-dependent gene transcription, we used a mammalian two-hybrid system to measure c-Jun activation (Fig. 6 ). Contrary to observed effects on kinase activity, here MKP2 was highly efficient at reducing activation of c-Jun both in the presence and absence of co-transfected JNK1. Because c-Jun-coupled luciferase activity represents the effects of JNK (and c-Jun) activity integrated over an extended period of time, it is likely that the apparent discrepancies between kinase and luciferase assays reflect the activity of endogenous JNKs, for which MKP2 may be a more specific inhibitor. Furthermore, although transfection of JNK1 may provide a convenient substrate for the actions of MKPs, the coupling of transfected JNKs to the nuclear target c-Jun in COS-7 cells had not been previously examined (6) . Although both JNK1 and JNK2 phosphorylate the NH 2 -terminal activation domain of c-Jun, activation of c-Jun by JNK2 is as much as 10-fold greater than that of JNK1, correlating with the increased binding of c-Jun to JNK2 (12, 29) . To determine whether selective inhibition of JNK2 by MKP2 contributed to the results of the luciferase assays, we examined the actions of each phosphatase on JNK2 kinase activity (Fig. 7) , revealing that this isoform was a suitable substrate for either MKP1 or MKP2. We suggest that the measurement of JNK kinase activities may only partially signify MKP's physiologic actions, which may be more appropriately assessed by measurement of the activation of c-Jun.
MKPs are immediate early genes that are rapidly induced by serum (3) and by NGF (9); however, the physiological role of newly synthesized MKPs has not been clearly established. In PC12 cells, NGF produces significant induction of MKP1 mRNA but does not result in diminished ERK activity, suggesting other possible substrates (24) . Although JNKs also can be activated via Ras-dependent pathways (35) , NGF is a poor activator of JNKs. 2, 3 To explore whether NGF can reduce JNK activity with kinetics consistent with induction of MKP protein, we examined JNK activity in PC12 cells exposed to UV irradiation. Pretreatment with NGF blunted JNK activation by UV light, with a maximal effect of NGF seen when pretreatment was timed 90 -120 min prior to the onset of UV irradiation, 2 consistent with a requirement for new protein synthesis. Other studies have also demonstrated potentiation of UV-induced increase in JNK activity after treatment with cyclohexamide, again suggesting that inactivation of JNKs requires new protein synthesis (8, 23) . Since MKPs are labile proteins (3), the maximal effect of newly synthesized MKPs on UV-stimulated JNK activity may be blunted by the inhibition of MKP synthesis following UV treatment (39) . Despite this limitation, induction of MKPs by NGF correlated with a significant reduction in JNK stimulation, while ERK activity has been shown to remain unaffected during the same time course (9, 24) .
The physiological significance of MKP inactivation of JNKs following NGF treatment may be in the regulation of programmed cell death, or apoptosis (49) . JNK activation is required for apoptosis in PC12 cells triggered by NGF withdrawal or MEKK activation (50) . Recent studies have proposed that the choice between neurotrophic and apoptotic responses in PC12 cells and other cells is controlled by a balance of activity between ERKs and JNKs (50, 51) . Since transcription of MKPs is partially dependent on ERK activity (46), 3 MKP inhibition of JNKs may provide a mechanism coupling ERK activation to JNK inactivation following NGF stimulation of PC12 cells.
